The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so uh Shelley Wong who's a very distinguished breast surgeon down at Duke has really been a force in the development of these trials where they are doing more or less what you proposed which is what if you just took it out and followed it uh and see what happens and in in some um instances they're even they're not even doing that excisional biopsy
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
no so the interesting thing about dcis is it's never treating dcis has actually never been shown to affect mortality because you're so far ahead of the diagnosis uh that um there probably isn't a survival benefit